CMG901

AstraZeneca strengthens its oncology R&D with in-licensing of CMG901 from China-based biotech KYM Biosciences
Medical Marketing and Media
Fri, 02/24/23 - 09:16 am
AstraZeneca
CMG901
antibody-drug conjugate
gastric cancer
KYM Biosciences